Reshma Rangwala
2020
In 2020, Reshma Rangwala earned a total compensation of $455.7K as Chief Medical Officer at Versartis.
Compensation breakdown
| Non-Equity Incentive Plan | $33,200 |
|---|---|
| Option Awards | $311,678 |
| Salary | $108,582 |
| Other | $2,286 |
| Total | $455,745 |
Rangwala received $311.7K in option awards, accounting for 68% of the total pay in 2020.
Rangwala also received $33.2K in non-equity incentive plan, $108.6K in salary and $2.3K in other compensation.
Rankings
In 2020, Reshma Rangwala's compensation ranked 11,260th out of 13,090 executives tracked by ExecPay. In other words, Rangwala earned more than 14.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,260 out of 13,090 | 14th |
Division Manufacturing | 4,821 out of 5,624 | 14th |
Major group Chemicals And Allied Products | 1,999 out of 2,257 | 11th |
Industry group Drugs | 1,744 out of 1,957 | 11th |
Industry Pharmaceutical Preparations | 1,290 out of 1,462 | 12th |
Source: SEC filing on July 23, 2021.
Rangwala's colleagues
We found four more compensation records of executives who worked with Reshma Rangwala at Versartis in 2020.